Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment

SAN ANTONIO--(BUSINESS WIRE)--The Center for Medicare & Medicaid Services (CMS) and its Hospital Compare website have U.S. hospitals focused on reducing healthcare associated infections (HAIs). As hospitals face decreasing reimbursements and increased public scrutiny, many facilities are evaluating new technologies for room disinfection as a means of improving patient safety.

A team of researchers that included Dr. Curtis Donskey recently published a study entitled “Evaluation of a Pulsed Xenon Ultraviolet (PX-UV) Disinfection System for Reduction of Healthcare-Associated Pathogens in Hospital Rooms” in Infection Control & Hospital Epidemiology (ICHE). According to the study published in January 2015, “the PX-UV device has some important potential advantages over other UV disinfection devices.”

The study showed that Xenex Disinfection Services’ PX-UV device significantly reduced the contamination of C. diff, MRSA and VRE on frequently touched surfaces in the real-world hospital environment. The study also indicated that pathogen concentration, organic load and shading (shadows) do not have an impact on the efficacy of the Xenex device. This is important because these conditions most accurately reflect the real-world hospital setting. The ICHE authors also noted that two separate studies have reported a reduction in C. diff infections when hospitals used the Xenex PX-UV device to disinfect their facilities.

“We are pleased with the results of this new environmental study,” said Dr. Mark Stibich, co-founder and Chief Scientific Officer of Xenex. “We encourage interested individuals to read the entire study because it makes several valuable points. Most importantly, while glass slide tests may have some utility for evaluating UV disinfection, this new environmental data demonstrates that the Xenex disinfection system works well in a hospital. As Dr. Donskey noted, Xenex devices have several potential advantages over other UV disinfection devices – Xenex devices are faster than mercury systems, don’t contain toxic mercury and are not affected by the organic load found in a hospital room.”

President Obama recently brought the issue of multi-drug resistant organisms to a national security level and issued an Executive Order to stop the spread of drug resistant superbugs. Xenex’s patented Germ-Zapping Robots™ use pulsed xenon UV light to destroy the viruses, bacteria, mold, fungus and bacterial spores in the patient environment that cause infections. The intense, broad-spectrum light penetrates the pathogens’ cell walls, causing the DNA to fuse instantly, rendering them unable to reproduce or mutate. Uniquely designed for ease of use and portability, a hospital’s environmental services staff can operate the Xenex device without disrupting hospital operations and without the use of expensive chemicals. With a five-minute disinfection cycle, the robot disinfects dozens of rooms per day, including patient rooms, operating rooms (ORs), equipment rooms, emergency rooms, intensive care units (ICUs) and public areas.

The Xenex robot contains no mercury or hydrogen peroxide, and it is the only UV disinfection system that uses xenon, an environmentally-friendly inert gas, to create UV light. Its patented technology is more intense than mercury UV systems and enables Xenex's Germ-Zapping Robots to disinfect 30-62 hospital rooms per day (according to Xenex customers). Pulsed xenon emits high intensity UV-C light across a broad germicidal spectrum (200-280 nanometers versus the single spectrum of 253.7 nanometers for mercury bulbs). The only non-mercury UV room disinfection solution is provided by Xenex.

“We are pleased that Dr. Donskey noted the safety hazards associated with disposal or exposure to mercury in this study. There are dozens of companies marketing mercury disinfection devices and most of those vendors do not disclose that their devices contain mercury,” said Morris Miller, CEO of Xenex. “Hospital decision-makers need to understand the significant scientific differences between UV light technologies as they evaluate room disinfection systems. The goal of room disinfection is to provide a safe environment for patients and healthcare workers. This ICHE study clearly establishes the fact that in real-world hospital environments, the Xenex device is capable of quickly destroying pathogens on surfaces. We believe that the most important evidence is an actual decrease in patient infections, which only Xenex customers have reported in peer-reviewed studies.”

Although the ICHE study showed that all types of UV worked well when disinfecting glass slides, the data showed that the Xenex robot significantly reduced MRSA, VRE and C.diff contamination in actual hospital situations. This statistically significant reduction is encouraging because in one arm of the study there was no manual cleaning of the room before use of the PX-UV device, which indicates that Xenex’s PX-UV device caused the reduction in pathogens.

More than 250 U.S. hospitals, Veterans Affairs (VA) and Department of Defense (DOD) facilities in the U.S. are using the Xenex room disinfection system, which has proven to be 20 times more effective than standard chemical cleaning practices. A study published in the August 2013 issue of the American Journal of Infection Control (AJIC) reported that Cooley Dickinson Hospital experienced a 53 percent decrease in the rate of hospital-acquired C.diff infections after implementing the Xenex system. A study published in 2013 in the Journal of Infection Prevention reported that Cone Health experienced a 56 percent reduction in its rate of hospital-acquired MRSA infections after implementing an infection prevention program that included Xenex’s room disinfection system. A study published in the June 2014 issue of AJIC reported that Westchester Medical Center experienced a 20 percent decrease in HAI rates after implementing the Xenex germ-zapping robot despite only treating a portion of room discharges.

Source: http://www.businesswire.com

January 14th 2015 back

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more